BELLUS Health to Participate in the Jefferies Healthcare Conference
businesswire.com
news
2022-06-01 00:00:00

June 01, 2022 07:00 AM Eastern Daylight Time LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) ('BELLUS Health' or the 'Company'), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough ('RCC') and other cough hypersensitivity indications, today announced that Roberto Bellini, BELLUS Health's President and Chief Executive Officer, will be participating in a fireside chat at the Jefferies Healthcare Conference, being held in New York, NY from June 8-10, 2022.
